An Agent-Based Model for Integrated Contagion and Regulation of Negative Mood

Through social interaction, the mood of a person can affect the mood of others. The speed and intensity of such mood contagion can differ, depending on the persons and the type and intensity of their interactions. Especially in close relationships the negative mood of a depressed person can have a serious impact on the moods of the ones close to him or her.For short time durations, contagion may be the main factor determining the mood of a person; however, for longer time durations individuals also apply regulation mechanisms to compensate for too strong deviations of their mood. Computational contagion models usually do not take into account such regulation.This paper introduces an agent-based model that simulates the spread of negative mood amongst a group of agents in a social network, but at the same time integrates elements from Gross’ emotion regulation theory, as the individuals’ efforts to avoid a negative mood.Simulation experiments under different group settings pointed out that the model is able to produce realistic results, that explain negative mood contagion and emotion regulation behaviours posed in the literatur

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To identify further cancer risk-modifying loci, we performed a multi-stage GWAS of 11,705 BRCA1 carriers (of whom 5,920 were diagnosed with breast and 1,839 were diagnosed with ovarian cancer), with a further replication in an additional sample of 2,646 BRCA1 carriers. We identified a novel breast cancer risk modifier locus at 1q32 for BRCA1 carriers (rs2290854, P = 2.7×10-8, HR = 1.14, 95% CI: 1.09-1.20). In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4×10-8, HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4×10-8, HR = 1.20, 95% CI: 1.17-1.38). The 4q32.3 locus was not associated with ovarian cancer risk in the general population or BRCA2 carriers, suggesting a BRCA1-specific associat

Peer and Authority Pressure in Information-Propagation Models ⋆

Abstract. Existingmodels ofinformation diffusion assume thatpeer influence is the main reason for the observed propagation patterns. In this paper, we examine the role of authority pressure on the observed information cascades. We model this intuition by characterizing some nodes in the network as “authority ” nodes. These are nodes that can influence large number of peers, while themselves cannot be influenced by peers. We propose a model that associates with every item two parameters that quantify the impact of the peer and the authority pressure on the item’s propagation. Given a network and the observed diffusion patterns of the item, we learn these parameters from the data and characterize the item as peer- or authority-propagated. We also develop a randomization test that evaluates the statistical significance of our findings and makes our item characterization robust to noise. Our experiments with real datafrom onlinemediaandscientific-collaboration networksindicate that there is a strong signal of authority pressure in these networks.

Molecular genetics and economics

The costs of comprehensively genotyping human subjects have fallen to the point where major funding bodies, even in the social sciences, are beginning to incorporate genetic and biological markers into major social surveys. How, if at all, should economists use and combine molecular genetic and economic data from these surveys? What challenges arise when analyzing genetically informative data? To illustrate, we present results from a "genome-wide association study" of educational attainment. We use a sample of 7,500 individuals from the Framingham Heart Study; our dataset contains over 360,000 genetic markers per person. We get some initially promising results linking genetic markers to educational attainment, but these fail to replicate in a second large sample of 9,500 people from the Rotterdam Study. Unfortunately such failure is typical in molecular genetic studies of this type, so the example is also cautionary. We discuss a number of methodological challenges that face researchers who use molecular genetics to reliably identify genetic associates of economic traits. Our overall assessment is cautiously optimistic: this new data source has potential in economics. But researchers and consumers of the genoeconomic literature should be wary of the pitfalls, most notably the difficulty of doing reliable inference when faced with multiple hypothesis problems on a scale never before encountered in social science

Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms.

With the introduction of large-scale molecular profiling methods and high-throughput sequencing technologies, the genomic features of most lymphoid neoplasms have been characterized at an unprecedented scale. While the principles for the classification and diagnosis of these disorders, founded on a multidimensional definition of disease entities, have been consolidated over the past 25 years, novel genomic data have markedly enhanced our understanding of lymphomagenesis and enriched the description of disease entities at the molecular level. Yet the current diagnosis of lymphoid tumors is largely based on morphological assessment and immunophenotyping, with only few entities being defined by genomic criteria. This paper, which accompanies the International Consensus Classification of mature lymphoid neoplasms, will address how established assays and newly developed technologies for molecular testing already complement clinical diagnoses and provide a novel lens on disease classification. More specifically, their contributions to diagnosis refinement, risk stratification and therapy prediction will be considered for the main categories of lymphoid neoplasms. The potential of whole-genome sequencing, circulating tumor DNA analyses, single-cell analyses and epigenetic profiling will be discussed, as these will likely become important future tools for implementing precision medicine approaches in clinical decision-making for patients with lymphoid malignancies